NCI scientists, along with experts from other government agencies and academic medical centers, have launched a joint effort to help FDA evaluate commercially available antibody tests for SARS-CoV-2, the coronavirus that causes COVID-19.
from Cancer Currents: An NCI Cancer Research Blog https://ift.tt/3b80e0s
from Cancer Currents: An NCI Cancer Research Blog https://ift.tt/3b80e0s